Related by context. All words. (Click for frequent words.) 67 OHR/AVR# 67 AA Amyloidosis 66 Cancer Cachexia 66 cachexia 66 Squalamine 65 Natalizumab 64 dual endothelin receptor antagonist 64 Hydroxyurea 64 Hypoparathyroidism 64 NAGS deficiency 64 benign prostatic hypertrophy BPH 64 Rheumatoid 64 Safinamide 64 Acute Renal Failure 64 Interferon Beta 64 Myelodysplastic Syndrome 63 Pulmonary hypertension 63 Pemphigus 63 Mucositis 63 Atypical Hemolytic Uremic Syndrome 63 neutropenic patients 63 Lisofylline 63 Eculizumab 63 Toxicities 63 thetreatment 63 EVIZON TM 63 Myelofibrosis 63 Diabetic Macular Edema 63 diabetic kidney 63 Treating Chronic 63 Late Breaker 63 Ischemic 63 Factor VIIa 63 Tyrosine Kinase Inhibitor 63 CYT# potent vascular disrupting 63 PAOD 63 Movement Disorder 63 systemic fungal infections 62 Arrhythmias 62 Overactive Bladder 62 HIV HCV coinfected 62 Autoimmune Diseases 62 Rheumatoid Arthritis RA 62 pulmonary arterial hypertension PAH 62 Fabry Disease 62 Psoriatic arthritis 62 II Clinical Trial 62 Critical Limb Ischemia CLI 62 neurotrophic 62 Pemphigus Vulgaris 62 Bisphosphonate 62 Adjunctive 62 Chronic lymphocytic leukemia 62 Bronchiectasis 62 Alzheimer Disease AD 62 Myelodysplastic Syndrome MDS 62 PEGylated interferon beta 1a 62 Diabetic neuropathy 62 Angiotensin II 62 complement inhibitor eculizumab 62 anterior uveitis 62 Chronic Prostatitis 62 Genetic Basis 62 Antiviral Therapy 62 CP CPPS 62 Benign Prostatic Hyperplasia 62 Investigational Treatment 62 Immune Mediated 62 cancer cachexia 62 Myelodysplastic syndromes MDS 62 Hormone Refractory Prostate Cancer 62 Microplasmin 62 Thromboembolic 61 Bevacizumab 61 Hemophilia B 61 Hyperkalemia 61 Systemic Lupus Erythematosus 61 Pulmonary Hypertension 61 Gastrointestinal Cancer 61 Sipuleucel T 61 Malignant Melanoma 61 choroidal neovascularization 61 Myelodysplastic Syndromes 61 Oral Fingolimod 61 selective inhibition 61 transthyretin TTR mediated amyloidosis 61 Metastatic Melanoma 61 intermittent claudication 61 Female Sexual Arousal 61 postoperative ileus 61 chronic thromboembolic pulmonary 61 Hyperlipidemia 61 Hepatocellular Carcinoma 61 Metastatic Prostate Cancer 61 CVBT #H 61 Alequel 61 Placebo Controlled Study 61 immunomodulatory therapy 61 progressive neurodegenerative disorder 61 SYN# 61 Prediabetes 61 thrombocytosis 61 trastuzumab Herceptin ® 61 Meets Primary Endpoint 61 recurrent glioma 61 recurrent glioblastoma multiforme 61 rFVIIa 61 Hypotension 61 Diabetic Neuropathy 61 Neuroprotective Effects 61 Tolvaptan 61 Lymphocytic 61 Interferon beta 61 Peripheral Artery Disease 61 Biological Therapy 61 induce orthostatic hypotension 61 kidney urologic 61 Cytotoxicity 61 Malignancies 61 anemia thrombocytopenia 61 HQK 61 Chronic Sinusitis 61 Angioedema 61 Phase 2b Clinical Trial 61 neovascular 61 diabetes dyslipidemia 61 inflammatory bowel syndrome 61 occlusive disease 61 immunomodulatory agents 61 riociguat 61 CTAP# Capsules 61 Endothelin 61 Renal Cell Carcinoma 61 invasive aspergillosis 61 Exacerbation 61 Bortezomib 61 Liprotamase 61 nonalcoholic steatohepatitis NASH 61 SABCS 61 psoriatic arthritis PsA 61 SIADH 61 Vandetanib 61 MELAS 60 5 HT6 receptor 60 Pemetrexed 60 Cutaneous T 60 Multiple Myeloma MM 60 Cardiotoxicity 60 ThGRF 60 Progressive Multifocal Leukoencephalopathy 60 Pharmacologic 60 pan HDAC inhibitor 60 antithrombotic therapy 60 mGluR2 NAM 60 Dendritic Cells 60 Corticosteroids 60 Heart Failure Patients 60 hypophosphatasia 60 Romiplostim 60 systemic amyloidosis 60 ADAMTS# 60 lipohypertrophy 60 RAPAFLO R 60 leukoencephalopathy 60 Advanced Renal Cell 60 Malignant Glioma 60 Diabetic Macular Edema DME 60 CIPN 60 Iron Overload 60 vidofludimus 60 Diabetic nephropathy 60 Subclinical 60 Epstein Barr Virus 60 pemphigus vulgaris 60 non alcoholic steatohepatitis 60 Thiazolidinediones 60 SHPT 60 Cognitive Deficits 60 Neuropathic Pain 60 Vulvar 60 Microalbuminuria 60 Pulmonary Arterial Hypertension 60 Neovascular Age Related Macular 60 oral FTY# 60 ASH Annual Meeting 60 P#X# 60 Spasticity 60 diarrhea predominant irritable 60 See CLINICAL PHARMACOLOGY 60 leiomyomas 60 Bazedoxifene 60 Comorbid 60 Xyfid TM 60 primary hyperparathyroidism 60 Acute Heart Failure 60 #beta HSD1 60 Carfilzomib 60 Trastuzumab 60 angiogenesis inhibition 60 Hematology Annual Meeting 60 Phase 2a Trial 60 Mouse Model 60 Parkinson Disease PD 60 anti angiogenic agent 60 artery stenosis 60 ALN TTR 60 invasive candidiasis 60 Fingolimod 60 schizophrenia CIAS 60 Inflammatory Diseases 60 Chemotherapy induced 60 Acute myeloid leukemia 60 ECTRIMS 60 inhibitor RG# 60 Sarcopenia 60 pouchitis 60 Mitoxantrone 60 mycosis fungoides 60 deferiprone 60 Inflammatory Bowel Diseases 60 Interstitial cystitis 60 Bronchiolitis 60 Endometrial cancer 60 Glucocorticoid 60 Fondaparinux 60 Cytokines 60 Phase 2a Clinical Trial 60 Antithrombotic 60 Diabetic Retinopathy 60 endometrial hyperplasia 60 Lipodystrophy 60 B Cell Lymphoma 60 infliximab Remicade 60 Decitabine 60 Benign Prostatic Hyperplasia BPH 60 Endothelial 60 PICSO ® 60 EVIZON ™ 60 Disease Progression 60 CIMZIA ™ 60 noninfectious uveitis 60 Alzheimer disease cognitive impairment 60 Immunotherapeutic 60 allogeneic HSCT 60 Hemorrhagic Stroke 60 Trodusquemine 60 metastatic malignant 60 sJIA 60 oral prodrug 60 aromatase inhibitors AIs 60 rheumatic diseases 60 Retinopathy 60 Neutropenia 60 Non Alcoholic Fatty 60 TMS Therapy 60 erythematosus 60 Fibromyalgia Syndrome FMS 60 Therapeutics TCT scientific 60 Hyperuricemia 60 Teriparatide 59 debilitating complication 59 Autoimmunity 59 vWD 59 Relapsing Remitting Multiple Sclerosis 59 Hematologic 59 ADPKD 59 Bucindolol 59 Peripheral Arterial 59 Radioimmunotherapy 59 Central Retinal Vein 59 GRNCM1 59 secondary hyperparathyroidism 59 liposomal amphotericin B 59 #th Interscience Conference 59 pancreatic insufficiency 59 dyslipidaemia 59 gastro esophageal reflux 59 Mipomersen 59 arterial calcification 59 gastrointestinal stromal tumors GIST 59 Enkephalin 59 malignant lymphomas 59 Anaplastic 59 Oral Mucositis 59 Skeletal Muscle 59 Hematology ASH Annual Meeting 59 Leukemias 59 Photodynamic Therapy 59 antiphospholipid syndrome 59 R lenalidomide 59 cytomegalovirus infection 59 Aliskiren 59 Pancreatic 59 Interstitial Cystitis 59 Enzyme Replacement Therapy 59 VA# [002] 59 muscular dystrophies 59 CIMZIA TM certolizumab pegol 59 TTR amyloidosis 59 Aflibercept 59 Tasimelteon 59 Polyneuropathy 59 Systemic lupus erythematosus 59 Liver transplantation 59 Systemic Sclerosis 59 Degarelix 59 panobinostat 59 Critical limb ischemia 59 antiplatelet therapies 59 Idiopathic Pulmonary Fibrosis 59 NSAID induced 59 Glucocorticoids 59 steroid refractory ulcerative 59 Sezary syndrome 59 Clinical Trial Results 59 transplantation HCT 59 debilitating autoimmune 59 Glioblastoma Multiforme 59 Ventricular Tachycardia 59 superficial bladder cancer 59 Liver Failure 59 Irritable Bowel 59 Dasatinib 59 Prolongs Survival 59 Trigeminal Neuralgia 59 perioperative complications 59 anticholinergic agents 59 Thrombocytopenia 59 chronic renal disease 59 endotoxemia 59 LHRH antagonists 59 Temsirolimus 59 Patients Receiving 59 fibrotic disease 59 parkinsonian symptoms 59 Oral Presentation 59 Alemtuzumab 59 Radiofrequency Ablation RFA 59 HER2 overexpression 59 hyperprolactinemia 59 Chronic Lymphocytic Leukemia 59 INTEGRILIN R 59 Relapsing Multiple Sclerosis 59 Phase Ib Clinical Trial 59 Metabolic Endocrinology 59 lung fibrosis 59 Actinic Keratosis 59 Idiopathic pulmonary fibrosis 59 diabetic gastroparesis 59 Denufosol 59 Chronic Heart Failure 59 posterior uveitis 59 thalidomide Thalomid 59 Restless Legs Syndrome RLS 59 Cancers Symposium 59 Castration Resistant Prostate Cancer 59 Pyridorin 59 lupus nephritis 59 Metastatic Colorectal Cancer 59 myelofibrosis polycythemia vera 59 BZL# 59 Occlusive Disease 59 herpes labialis 59 lysosomal storage disorder 59 metastatic bone 59 Prostatitis 59 C1 INH deficiency 59 Allergic Rhinitis 59 chronic granulomatous disease 59 TRO# 59 atypical Hemolytic Uremic Syndrome 59 Preclinical Study 59 Peripheral Vascular Disease 59 Soft Tissue Sarcoma 59 Pulmonary arterial hypertension 59 #F FDG PET 59 recurrent glioblastoma 59 nephropathic cystinosis 59 Thrombotic 59 Radiofrequency Ablation 59 antiapoptotic 59 underdiagnosis 59 immunosuppressive therapies 59 Neoplasms 59 neuroprotective agent 59 ST Elevation Myocardial 59 systemic mastocytosis 59 Juvenile Idiopathic Arthritis 59 Autoimmune Disease 59 RhuDex ® 59 Tumor Progression 59 Fibrosis 59 Nilotinib 59 Haptoglobin 59 Anthracycline 59 venous stasis ulcers 59 imatinib Gleevec ® 59 Peripheral neuropathy 59 Patients Treated With 59 polycythemia vera essential thrombocythemia 59 Leber Hereditary Optic Neuropathy 59 paroxysmal nocturnal hemoglobinuria 59 INCB# [003] 59 neurological manifestations 59 Rasagiline 59 postoperative atrial fibrillation 59 Pharmacological 59 symptomatic benign prostatic 59 colorectal carcinoma 59 acadesine 59 torsade de pointes 58 Omalizumab 58 liver fibrosis 58 Enzastaurin 58 Follicular Lymphoma 58 Antitumor Activity 58 Hematology Meeting 58 Overactive Bladder OAB 58 cystic fibrosis chronic pancreatitis 58 Davunetide 58 venous thromboembolic disease 58 paraneoplastic 58 Neulasta ® 58 Dalbavancin 58 Antiangiogenic 58 p# inhibitor 58 Peripheral arterial disease 58 Targeted Therapies 58 overactive bladder OAB 58 RNAi therapeutic targeting 58 Ischaemic 58 bladder carcinoma 58 Medical Oncology ESMO 58 Advanced Melanoma 58 Bipolar Disorders 58 Torsades de Pointes 58 DAS# Fludase ® 58 Gastroparesis 58 Graft Versus Host 58 essential thrombocythemia ET 58 Phase 2b Trial 58 relapsing multiple sclerosis 58 Hereditary angioedema HAE 58 #:#-# [031] 58 Lipsovir ® 58 idiopathic thrombocytopenic purpura ITP 58 arterial thrombosis 58 Estrogen Receptor 58 Aviptadil 58 cardiac dysfunction 58 Vidofludimus 58 myasthenia gravis MG 58 Blinatumomab 58 Diabetes mellitus 58 AEG# 58 direct thrombin inhibitors 58 LHON 58 cytopenias 58 verteporfin 58 bone metastasis 58 systemic lupus erythematosus psoriasis 58 Valsartan 58 Pioglitazone 58 coagulation abnormalities 58 Controlled Release 58 Fulvestrant 58 IL# PE#QQR 58 atherosclerotic vascular disease 58 Androgen 58 squamous cell lung cancer 58 Gastrointestinal GI 58 gastrointestinal malignancies 58 DFMO 58 Naive Patients 58 urothelial cancer 58 candidemia 58 Phase III Clinical Trial 58 Critical Limb Ischemia 58 Neuropathic 58 Hormone Receptor Positive 58 nephrotoxicity 58 receptor antagonism 58 hypovitaminosis D 58 rare autosomal recessive 58 anti amnesic 58 AA amyloidosis 58 Retinoic Acid 58 Irritable Bowel Syndrome IBS 58 chronic opioid 58 depsipeptide 58 Idiopathic 58 prostate cancer HRPC 58 Acute Ischemic Stroke 58 Neovascular 58 acetonide FA 58 Minimally Invasive Treatment 58 Adult Stem Cell Therapy 58 thrombotic complications 58 Gastrointestinal Cancers Symposium 58 immunocompetent patients 58 SNT MC# 58 Irinotecan 58 ATTR CM 58 Annual Interscience Conference 58 lichen planus 58 Ischemia 58 fosbretabulin 58 prostate cancer CaP 58 diabetes mellitus T2DM 58 Cimzia TM 58 glucocorticoid therapy 58 INS# [001] 58 Ranolazine 58 Pseudomonas aeruginosa infections 58 cardiac insufficiency 58 Lupus Nephritis 58 Randomized Phase 58 Monoclonal Antibodies 58 Clinical Outcome 58 Annual Transcatheter Cardiovascular 58 Subgroup Analysis 58 Chronic HCV 58 Portal Hypertension 58 Magnesium deficiency 58 Overactive bladder 58 tafamidis 58 CCX# 58 Adjuvant chemotherapy 58 smoldering myeloma 58 ASCO GI 58 neutropenia dehydration dyspnea 58 Neurological Disorder 58 Ulcerative colitis 58 malignant ascites 58 Hepatocellular Carcinoma HCC 58 Atherosclerosis 58 Hedgehog Pathway Inhibitor 58 Complicated Skin 58 Epratuzumab 58 Cholinesterase inhibitors 58 abacavir Ziagen 58 arthritis PsA 58 proliferative diabetic retinopathy 58 overactive bladder syndrome 58 Hsp# Inhibitor 58 Prostaglandins 58 Gaucher Disease 58 chronic rhinosinusitis CRS 58 hyperphenylalaninemia HPA due 58 elevated triglyceride levels 58 Bulimia Nervosa 58 Nocturia 58 hormone refractory 58 mixed hyperlipidemia 58 #th Annual Interscience 58 Host Disease GvHD 58 acute PAO 58 Papillary 58 ATL/TV# 58 pathologic myopia 58 Erlotinib 58 motor neuron degeneration 58 ON #.Na 58 Diabetic Peripheral Neuropathy 58 arthropathy 58 diabetic polyneuropathy 58 Pegylated Interferon 58 assessing T DM1 58 homozygous familial hypercholesterolemia 58 psoriasis psoriatic arthritis 58 Hypogonadism 58 Bivalirudin 58 delayed CINV 58 heparin induced thrombocytopenia 58 Clinical Trial Data 58 HDAC Inhibitor 58 Aortic stenosis 58 chronic myocardial ischemia 58 ASBMR 58 dopaminergic therapy 58 Peritonitis 58 oropharyngeal candidiasis 58 SCCHN 58 diabetic microvascular complications 58 Intravitreal 58 ErbB2 positive 58 Drug Candidate 58 chronic prostatitis 58 Warfarin Coumadin 58 IV NSCLC 58 pharmacologic intervention 58 either acutely decompensated 58 adrenalectomy 58 CYP #D# 58 idiopathic myelofibrosis 58 Female Urology 58 RhuDex 58 phase IIb trial 58 Parathyroid 58 Novel Oral 58 ADA Scientific Sessions 58 Neuro Oncology SNO 58 Early Diagnosis 58 Tanespimycin 58 metastatic gastric 58 pT2 58 Ankylosing Spondylitis 58 Signaling Pathway 58 Pathogenesis 58 Randomized Study 58 Clinical Oncology Annual Meeting 58 membranous nephropathy 58 demyelinating 58 Fibrillex TM 58 choriocarcinoma 58 Graft versus 58 Hematological Malignancies 58 Polycystic Ovary Syndrome 58 retinal vein occlusion 58 Deforolimus 58 MPGN 58 Friedreich Ataxia 58 HeFH 58 Chronic Rhinosinusitis 58 Chemotherapy ICAAC 58 Ribavirin causes 58 Bosentan 58 Preclinical Data 58 Diabetic Foot Ulcers 58 delafloxacin 58 Mouse Models 58 Epstein Barr Virus EBV 58 pancytopenia 58 Anti VEGF 58 Hypertrophic 58 Allogeneic 58 prokinetic agent 58 hyperammonemia 58 dysmenorrhea 57 Zarnestra 57 neovascular diseases 57 Exemestane 57 Metabolic Disease 57 adrenal insufficiency 57 Bacterial Vaginosis 57 overactive bladder symptoms 57 Disease Modifying 57 Aortic Stenosis 57 hepatorenal syndrome 57 inotropes 57 Ampligen ® 57 medically refractory 57 acute mania 57 Candida infection 57 Nonspecific 57 Hepatotoxicity 57 Phase III Pivotal Trial 57 Adjuvant Treatment 57 Frontotemporal Dementia 57 antiangiogenic therapy 57 Dual Antiplatelet Therapy 57 KRN# 57 Chronic Myeloid Leukemia 57 erlotinib Tarceva ® 57 Pelvic Organ Prolapse 57 rheumatoid arthritis osteoarthritis ankylosing 57 ECCMID 57 chronic rheumatic 57 Pooled Analysis 57 acute myocardial infarction MI 57 thromboembolic complications 57 Dysmenorrhea 57 fibromyalgia syndrome 57 dysmotility 57 Photodynamic therapy 57 PEGylated anti 57 hepatic encephalopathy 57 Leber Congenital Amaurosis LCA 57 gastrointestinal stromal tumor 57 adalimumab Humira 57 trimethoprim sulfamethoxazole 57 Heavy menstrual bleeding 57 Benign prostatic hyperplasia BPH 57 nonalcoholic steatohepatitis 57 enzastaurin 57 Tyrosine Kinase Inhibitors 57 metastatic neuroendocrine tumors 57 smoldering multiple myeloma 57 Neurodegenerative diseases 57 PNP inhibitor 57 Autoimmune diseases 57 Talabostat 57 EndoTAG TM -1 57 intravascular hemolysis 57 Acute Coronary Syndromes ACS 57 Neuroprotection 57 Chemokine Receptor 57 TEMODAL 57 cerebral vasospasm 57 Asthma COPD 57 Golimumab 57 LYSTEDA 57 Intravesical 57 Metastases 57 Nexavar sorafenib 57 T2DM 57 ACZ# 57 sorafenib tablets 57 Adjuvant therapy 57 antimetabolite 57 Fatty liver 57 Subarachnoid hemorrhage 57 bortezomib Velcade 57 Tumor Response 57 Tocilizumab 57 Onychomycosis 57 transthyretin amyloidosis 57 Ambrisentan 57 lexidronam injection 57 Duodenal 57 histone deacetylase inhibitor 57 catheter occlusion 57 IPAH 57 leukemia ALL 57 bacterial prostatitis 57 Periodontitis 57 Metabolic Disorders 57 Adenomas 57 atypical hemolytic uremic syndrome 57 GW# [003] 57 Symadex 57 myoclonus 57 Diabetic Foot Ulcer 57 ELACYT 57 Cytotoxic 57 antibody mediated 57 Neoplasia 57 Glioma 57 Cytarabine 57 Allosteric 57 Factor Xa inhibitors 57 HuMax EGFr 57 Surgical Treatment 57 Prodarsan R 57 Immunosuppression 57 Dyslipidemia 57 Etanercept 57 Varespladib 57 Cell Transplant 57 G6PD deficiency 57 Androgen Receptor 57 Epidermal Growth Factor Receptor 57 Acute Myocardial Infarction AMI 57 EBV infection 57 plasminogen activators 57 Chronic Hepatitis C 57 Bulimia nervosa 57 haematologic 57 Prostate Cancer Progression 57 vivo validation 57 Drug Prevents 57 Cytomegalovirus CMV 57 eosinophilic asthma 57 ATACAND 57 Comorbidities 57 lupus erythematosus 57 subcutaneous immunoglobulin 57 Stent Thrombosis 57 Phase IIb Trial 57 Glatiramer acetate 57 Advanced Heart Failure 57 post menopausal osteoporosis 57 systolic hypertension 57 progressive neurodegenerative 57 Chronic Bronchitis 57 CROI 57 Catheter Associated 57 Factor Receptor 57 Neovascular AMD 57 Myocarditis 57 Respiratory Syncytial Virus 57 pyridostigmine 57 Erythropoietic 57 SPIRIVA ® 57 Tacrolimus 57 SSc 57 Stomach Cancer 57 Reperfusion Injury 57 valvular heart 57 Catheter Ablation 57 Cutaneous 57 Venous thromboembolism 57 hypercholesterolemia 57 JAK2 inhibitor 57 compound AEZS 57 Beta Amyloid 57 SJIA 57 protein kinase inhibitor 57 Adenosine 57 post transplant lymphoproliferative 57 receptor tyrosine kinase inhibitor 57 Acute Decompensated Heart Failure 57 metastatic castration resistant 57 Beta Blocker 57 dasatinib Sprycel 57 peritumoral brain edema 57 Anticoagulant 57 Polycystic ovary syndrome PCOS 57 T1DM 57 thromboembolic 57 Renal Impairment 57 pemphigus 57 Valopicitabine 57 Diabetic Nephropathy 57 YONDELIS 57 GnRH agonists 57 Basal Cell Carcinoma 57 myelodysplastic myeloproliferative diseases 57 cervical lymph nodes 57 forodesine 57 Slow Progression 57 Recurrent Chest Wall 57 diabetic nephropathy 57 Paroxysmal Nocturnal Hemoglobinuria PNH 57 post herpetic neuralgia PHN 57 type 1diabetes 57 Ocrelizumab 57 Friedreich Ataxia FRDA 57 interstitial cystitis IC 57 Metastatic breast cancer 57 multiple myeloma MM 57 MEK inhibitor 57 TMP SMX 57 thromboembolic disease 57 Diabetic Patients 57 Endometrial 57 atherothrombotic 57 Dupuytren Disease 57 Schizoaffective Disorder 57 Chronic pancreatitis 57 cetuximab Erbitux 57 thromboembolism 57 Anti TNF 57 pulmonary hypertension PH 57 Lubiprostone 57 FASLODEX 57 SNT-MC#/idebenone 57 Therapeutics TCT 57 Antitumor activity 57 Tiotropium 57 ocular disorders 57 Triolex 57 disease GERD 57 myocardial fibrosis 57 opioid analgesia 57 Severe Sepsis 57 Legg Calvé Perthes disease 57 macrovascular events 57 Cystectomy 57 Adefovir 57 Myopathy 57 Hematological 57 Hypertriglyceridemia 57 A1PI 57 Endometrial Cancer 57 Pivotal Clinical Trial 57 non metastatic osteosarcoma 57 taxane resistant 57 Coronary Artery Bypass Graft 57 Progenitor Cells 57 Testosterone deficiency 57 idiopathic pulmonary fibrosis IPF 57 MGd 57 Hypoglycaemia 57 pharmacological therapies 57 tolvaptan 57 Cell Lymphoma 57 Hypercholesterolemia 57 EXJADE 57 Hemorrhagic 57 risedronate Actonel 57 Cushing Syndrome 57 Panzem 57 trial evaluating PRX# 57 teriflunomide 57 Resistant Hypertension 57 symptomatic intracranial 57 ATTR 57 MELAS syndrome 57 Novel Mechanism 57 Knee Osteoarthritis 57 primary Restless Legs 57 premenstrual syndrome PMS 57 primary immunodeficiency PI 57 Mitral Regurgitation 57 imatinib resistance 57 prostate carcinoma 57 Gastric Cancer 57 granulomatous 57 tumor necrosis 57 Fenretinide 57 Personalized Immunotherapy 57 Everolimus 57 Chronic Fatigue Syndrome CFS 57 Multiple sclerosis MS 57 Beneficial Effects 57 Therapeutic Potential 57 RhuDex R 57 neuronal dysfunction 57 familial amyloidotic polyneuropathy FAP 57 Acromegaly 57 EGFR inhibitors 57 C1 Inhibitor 57 Renal Cancer 57 R roscovitine 57 variceal bleeding 57 Elagolix 57 PYY #-# 57 proliferator activated receptor 57 therapeutic modality 57 ATTR PN 57 Neurodegenerative 57 Philadelphia Chromosome Positive 57 Lumbar Spine 57 Leydig cell 57 Cystic 57 Skin Structure Infections 57 Periodontal disease 57 antiinflammatory 57 gemcitabine Gemzar 57 Abstract Number 57 Statin therapy 57 Infected Patients 57 Lamotrigine 57 Capecitabine 57 Gene Linked 57 fatal neurodegenerative disorder 57 Dupuytren Contracture 57 Phase #/#a trial 57 Acute MI 57 Aggressive Reduction 57 anti arrhythmic drug 57 Proteinuria 57 Carcinomas 57 Parkinsonism 57 biphosphonates 57 Genitourinary Cancers Symposium 57 atrial fibrillation AFib 57 relapsing remitting MS RRMS 57 Growth Hormone Deficiency 57 macular degeneration diabetic retinopathy 57 Systemic Lupus Erythematosus SLE 57 androgen deficiency 57 MYCAMINE 57 variant angina 57 Doxil ® 57 Insulin Resistance 57 Chronic Pelvic Pain 57 Mimetics 57 Mitomycin C 57 Oesophageal 57 Previously Treated 57 Fibromyalgia Syndrome 56 β blockers 56 antiarrhythmic drug 56 BERKELEY CA UroToday.com 56 histone deacetylase HDAC inhibitor 56 hypoperfusion 56 Therapeutic Targets 56 Cinacalcet 56 Obstructive Sleep Apnea 56 bevacizumab Avastin 56 Familial Adenomatous Polyposis FAP 56 ACE Inhibitors 56 cMET 56 Intracerebral 56 ProSavin 56 Bisphosphonates 56 limb ischemia 56 Gleevec resistant 56 Silodosin 56 degenerative disorders 56 Fungal Infections 56 urolithiasis 56 parasitemia 56 Myeloid 56 prostate cancer mCRPC 56 epithelial tumors 56 hyperalgesia 56 Selective Cardiac Myosin Activator 56 Archexin 56 Pirfenidone 56 Noxafil 56 arterial hypertension 56 Peginterferon 56 spinal metastases 56 intracerebral hemorrhage ICH 56 Brentuximab Vedotin SGN 56 Chronic constipation